Atlas Trials

Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer

Clinical trial NCT03618810 · UNKNOWN

Trial details

NCT number
NCT03618810
Sponsor
Zhejiang Cancer Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Febrile Neutropenia
Start date
2019-01-20
Primary completion
2020-12-31
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.